MiMedx Group entered into a distribution agreement with Medtronic and SpinalGraft Technologies, a subsidiary of Medtronic.
MiMedx’s PURION processed allograft products will be available to Medtronic to market as a SpinalGraft Technologies spinal application. The agreement will help MiMedx expand its customer base and broaden physician access to the PURION.
